Nyalkaran Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 12-12-2024
- Company Age 2 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.00 Cr
as on 12-12-2024
About Nyalkaran Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹15.00 Cr.
Shailesh Golviya, Ashvinkumar Golaviya, Rajanikant Bhalala, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24290GJ2022PTC135829
- Company No.
135829
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nyalkaran Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashvinkumar Golaviya | Managing Director | 29-Sep-2022 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shailesh Golviya | Director | 29-Sep-2022 | Current |
Rajanikant Bhalala | Director | 29-Sep-2022 | Current |
Jaykumar Vadher | Director | 29-Sep-2022 | Current |
Chirin Golviya | Director | 29-Sep-2022 | Current |
Alpeshkumar Golaviya | Director | 29-Sep-2022 | Current |
Financial Performance of Nyalkaran Pharma.
Nyalkaran Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Nyalkaran Pharma?
Unlock access to Nyalkaran Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Nyalkaran Builders LlpActive 8 years 10 months
Shailesh Golviya, Ashvinkumar Golaviya and 2 more are mutual person
- Nyalkaran Retail Private LimitedActive 1 year 2 months
Shailesh Golviya, Ashvinkumar Golaviya and 2 more are mutual person
- Nyalkaran Food Private LimitedActive 8 months 1 day
Shailesh Golviya, Ashvinkumar Golaviya and 2 more are mutual person
- Nyalkaran Infraspace Private LimitedActive 6 months 28 days
Shailesh Golviya, Ashvinkumar Golaviya and 2 more are mutual person
- Nyalkaran Leisure Private LimitedActive 2 years 5 months
Shailesh Golviya, Ashvinkumar Golaviya and 2 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 07 Apr 2023 | ₹7.50 Cr | Open |
Others Creation Date: 28 Mar 2023 | ₹7.50 Cr | Open |
How Many Employees Work at Nyalkaran Pharma?
Nyalkaran Pharma has a workforce of 192 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyalkaran Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyalkaran Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.